Pharmas and medtechs flex brand protection among Top 100 New Brands for 2023

Biopharma and medtech brands made up a dozen of the Clarivate Top 100 New Brands for 2023, as the life science industries continued to show a muscular approach to protecting their intellectual property.

The  findings put the life science industries on favorable terms with consumer-facing giants like Apple (which counted five brands among the top 100), Huawei (5) and Hugo Boss (4) – all the more remarkable as pharma and medtech brands are generally not sold direct-to-consumer.

Source: Clarivate Trademark Strength Index and CompuMark data covering 145 million individual trademark records

Notable of this year’s list:

• BioNTech appears twice, first for the German biotech’s corporate brand, which achieved global household name status as a result of its revolutionary mRNA COVID-19 vaccine, and again for its BioNTainer mRNA production platform. BioNTainer features modular production units, GMP-compliant setup and personnel training, with each unit designed to function as a regional node in a global manufacturing network for rapid response to infectious disease outbreaks.
• Incyte also notches two mentions, first for the U.S.-based company’s topical JAK inhibitor for nonsegmental vitiligo and atopic dermatitis in patients ages 12 and up, OPZELURA™, and again for QPARIK®, a registration covering prospective treatments for oncological, autoimmune, hematological and treatment graft versus host disorders.
• Medtech is holding its own here, with multiple trademarks including Zimmer Biomet’s dental and spine business spinoff ZimVie and bioMerieux’s stackable benchtop automated immunoassay solution VIDAS® KUBE™.
• Across all sectors, the advent of AI was one of this year’s notable trends, and the inclusion of Bayer’s Cal.AI (Calantic™) radiology solutions suite reflects this.
• In geographic terms, this year’s life science brands leaned toward Europe, with Germany and Switzerland accounting for six, and France and the U.K. one apiece. U.S.-based companies accounted for three brands and South Korea one. Beyond the life sciences, this year’s report featured a very strong showing from companies based in Mainland China, accounting for 27 brands.

To identify the Top 100 New Brands for 2023, analysts used Clarivate global trademark data covering 145 million individual trademark records to analyze applications filed worldwide between 2021 and 2022 with a verbal element. Brands were scored based on market footprint and geographic/economic coverage for each.

Read the full report here, and to learn more about Clarivate brand IP intelligence and trademark analytics solutions, please contact us here. Learn more about the broader Clarivate connected data and solutions offerings for the life sciences here.

content_copy Copy link Copied